Change in pneumococcal susceptibility to azithromycin during treatment for acute otitis media

Pediatr Infect Dis J. 2007 Jul;26(7):647-9. doi: 10.1097/INF.0b013e3180618c02.

Abstract

Authorities have suggested restriction of azithromycin use as a principal strategy to contain the spread of azithromycin-nonsusceptible Streptococcus pneumoniae (ANSP). In 83 children persistently colonized by pneumococcus during and after treatment of acute otitis media, 17 acquired a new strain, 9 of which were less susceptible to azithromycin than the original isolate. New appearance of ANSP was documented after both beta-lactam and azithromycin exposure. ANSP is likely to disseminate even with significant reduction of azithromycin use unless other antibiotic use is decreased as well.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azithromycin / pharmacology*
  • Drug Resistance, Multiple, Bacterial*
  • Humans
  • Microbial Sensitivity Tests
  • Otitis Media / drug therapy*
  • Otitis Media / microbiology
  • Penicillins / pharmacology
  • Pneumococcal Infections / drug therapy*
  • Pneumococcal Infections / microbiology*
  • Streptococcus pneumoniae / drug effects*

Substances

  • Penicillins
  • Azithromycin